Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma
Clinical trial NCT00134082 · COMPLETED
Trial details
- NCT number
- NCT00134082
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2013-01-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.